Trial Profile
A Phase 1 Study To Assess The Pharmacokinetics, Safety, And Tolerability of Intravenous ACHN-490 Injection in Volunteers With Varying Degrees of Renal Dysfunction Compared to Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs Plazomicin (Primary)
- Indications Renal impairment
- Focus Pharmacokinetics
- Sponsors Achaogen
- 22 Jan 2019 Results of pooled analysis assessing the population pharmacokinetics for Plazomicin from 7 studies :NCT00822978, NCT01034774,NCT01462136,NCT01514929,NCT01096849,NCT01970371 and NCT02486627 were published in the Antimicrobial Agents and Chemotherapy
- 01 Oct 2018 Results published in the Antimicrobial Agents and Chemotherapy
- 19 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.